Karl Ruping

Karl Ruping is the CEO of Tiba Biotech. Karl has also served on the advisory board for Agrivida, Inc. and as a founder and investor board member for AgaMatrix. In addition, they have been an adjunct professor of law at Temple University.

Karl Ruping's educational career began with a Certificate of Computer Programming from Temple University. Karl continued their studies at the Massachusetts Institute of Technology, where they earned a research fellowship in electrical engineering and computer science. Ruping then went on to earn their Doctor of Law from the Boston University School of Law. After completing their J.D., they became a post-doctoral candidate at The University of Tokyo in the field of international intellectual property law. Finally, Ruping completed their education with a fellowship in East Asian studies from Harvard University.

Some direct reports include Christian Mandl - Interim Chief Science Officer, Jasdave Chahal - Chief Scientist, and Peter McGrath - Chief Financial Officer.